| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $416.4K | - | |
| CFO | 26.0K | $180.4K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $23.46 | $886,741.08 | -0.6% | |
| Jan 27, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $23.29 | $880,315.42 | -0.6% | |
| Jan 19, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $24.90 | $49,800.00 | -4.5% | |
| Jan 12, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $23.85 | $901,522.45 | -0.3% | |
| Jan 11, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 6,500 | $24.00 | $156,000.00 | -4.7% | |
| Jan 10, 2017 | Yu K Peony | Chief Medical Officer | Sell | 5,000 | $23.56 | $117,800.00 | -2.4% | |
| Dec 28, 2016 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $20.74 | $783,930.52 | -0.6% | |
| Dec 16, 2016 | Riggs Rory B67 | Director | Sell | 20,000 | $20.87 | $417,310.00 | -4.2% | |
| Dec 14, 2016 | Yu K Peony | Chief Medical Officer | Sell | 2,344 | $20.65 | $48,403.60 | -1.1% | |
| Dec 13, 2016 | Neff Thomas B | Chief Executive Officer | Sale+OE | 37,798 | $21.24 | $802,827.61 | -0.3% |